nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—BCL2—malignant glioma	0.564	1	CbGaD
Paclitaxel—MAP2—telencephalic ventricle—malignant glioma	0.00527	0.0583	CbGeAlD
Paclitaxel—Docetaxel—BCL2—malignant glioma	0.00282	0.605	CrCbGaD
Paclitaxel—MAPT—retina—malignant glioma	0.00222	0.0246	CbGeAlD
Paclitaxel—MAPT—telencephalon—malignant glioma	0.00205	0.0226	CbGeAlD
Paclitaxel—MAP4—embryo—malignant glioma	0.00198	0.0219	CbGeAlD
Paclitaxel—Docetaxel—EGFR—malignant glioma	0.00185	0.395	CrCbGaD
Paclitaxel—MAP4—brainstem—malignant glioma	0.00181	0.02	CbGeAlD
Paclitaxel—MAP4—retina—malignant glioma	0.00175	0.0193	CbGeAlD
Paclitaxel—MAP4—telencephalon—malignant glioma	0.00161	0.0178	CbGeAlD
Paclitaxel—MAPT—medulla oblongata—malignant glioma	0.00161	0.0178	CbGeAlD
Paclitaxel—MAP2—embryo—malignant glioma	0.00156	0.0172	CbGeAlD
Paclitaxel—MAPT—midbrain—malignant glioma	0.00147	0.0162	CbGeAlD
Paclitaxel—BCL2—telencephalon—malignant glioma	0.00146	0.0162	CbGeAlD
Paclitaxel—MAPT—spinal cord—malignant glioma	0.00143	0.0158	CbGeAlD
Paclitaxel—MAP2—brainstem—malignant glioma	0.00143	0.0158	CbGeAlD
Paclitaxel—MAP2—retina—malignant glioma	0.00138	0.0152	CbGeAlD
Paclitaxel—Skin hyperpigmentation—Carmustine—malignant glioma	0.00135	0.00821	CcSEcCtD
Paclitaxel—TUBB8—central nervous system—malignant glioma	0.00134	0.0148	CbGeAlD
Paclitaxel—Febrile neutropenia—Carmustine—malignant glioma	0.00134	0.00811	CcSEcCtD
Paclitaxel—Visual acuity reduced—Temozolomide—malignant glioma	0.00131	0.00793	CcSEcCtD
Paclitaxel—Febrile neutropenia—Temozolomide—malignant glioma	0.00129	0.00784	CcSEcCtD
Paclitaxel—Myasthenia—Carmustine—malignant glioma	0.00128	0.00777	CcSEcCtD
Paclitaxel—Oral candidiasis—Carmustine—malignant glioma	0.00127	0.00768	CcSEcCtD
Paclitaxel—MAP2—telencephalon—malignant glioma	0.00127	0.014	CbGeAlD
Paclitaxel—MAP4—medulla oblongata—malignant glioma	0.00126	0.014	CbGeAlD
Paclitaxel—Encephalopathy—Carmustine—malignant glioma	0.00125	0.0076	CcSEcCtD
Paclitaxel—Oral candidiasis—Temozolomide—malignant glioma	0.00122	0.00743	CcSEcCtD
Paclitaxel—Embolism—Temozolomide—malignant glioma	0.00121	0.00735	CcSEcCtD
Paclitaxel—Cyst—Carmustine—malignant glioma	0.0012	0.0073	CcSEcCtD
Paclitaxel—TUBB4A—embryo—malignant glioma	0.0012	0.0133	CbGeAlD
Paclitaxel—Hypokinesia—Carmustine—malignant glioma	0.00119	0.00723	CcSEcCtD
Paclitaxel—MAP4—midbrain—malignant glioma	0.00115	0.0128	CbGeAlD
Paclitaxel—Interstitial lung disease—Carmustine—malignant glioma	0.00114	0.0069	CcSEcCtD
Paclitaxel—Thrombosis—Carmustine—malignant glioma	0.00114	0.0069	CcSEcCtD
Paclitaxel—MAPT—cerebellum—malignant glioma	0.00114	0.0126	CbGeAlD
Paclitaxel—MAP4—spinal cord—malignant glioma	0.00113	0.0125	CbGeAlD
Paclitaxel—TUBB4A—brainstem—malignant glioma	0.0011	0.0122	CbGeAlD
Paclitaxel—Interstitial lung disease—Temozolomide—malignant glioma	0.0011	0.00667	CcSEcCtD
Paclitaxel—Influenza-like symptoms—Temozolomide—malignant glioma	0.00109	0.0066	CcSEcCtD
Paclitaxel—TUBB4A—retina—malignant glioma	0.00106	0.0118	CbGeAlD
Paclitaxel—TUBB8—brain—malignant glioma	0.00106	0.0118	CbGeAlD
Paclitaxel—Scotoma—Carmustine—malignant glioma	0.00106	0.00643	CcSEcCtD
Paclitaxel—Herpes zoster—Temozolomide—malignant glioma	0.00103	0.00626	CcSEcCtD
Paclitaxel—TUBB2B—retina—malignant glioma	0.00103	0.0114	CbGeAlD
Paclitaxel—Necrosis—Carmustine—malignant glioma	0.00103	0.00622	CcSEcCtD
Paclitaxel—Scotoma—Temozolomide—malignant glioma	0.00102	0.00621	CcSEcCtD
Paclitaxel—MAP2—medulla oblongata—malignant glioma	0.000995	0.011	CbGeAlD
Paclitaxel—Hyperaesthesia—Temozolomide—malignant glioma	0.000991	0.00601	CcSEcCtD
Paclitaxel—TUBB4A—telencephalon—malignant glioma	0.000979	0.0108	CbGeAlD
Paclitaxel—Rigors—Temozolomide—malignant glioma	0.000953	0.00578	CcSEcCtD
Paclitaxel—TUBB2B—telencephalon—malignant glioma	0.000946	0.0105	CbGeAlD
Paclitaxel—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.000946	0.00573	CcSEcCtD
Paclitaxel—TUBB4B—embryo—malignant glioma	0.000939	0.0104	CbGeAlD
Paclitaxel—MAPT—brain—malignant glioma	0.000923	0.0102	CbGeAlD
Paclitaxel—Extravasation—Carmustine—malignant glioma	0.000923	0.0056	CcSEcCtD
Paclitaxel—TUBB3—central nervous system—malignant glioma	0.000914	0.0101	CbGeAlD
Paclitaxel—MAP4—central nervous system—malignant glioma	0.000914	0.0101	CbGeAlD
Paclitaxel—Accidental injury—Carmustine—malignant glioma	0.00091	0.00552	CcSEcCtD
Paclitaxel—MAP2—midbrain—malignant glioma	0.000909	0.0101	CbGeAlD
Paclitaxel—TUBB—telencephalon—malignant glioma	0.000895	0.00989	CbGeAlD
Paclitaxel—TUBB1—central nervous system—malignant glioma	0.000894	0.00988	CbGeAlD
Paclitaxel—TUBB3—cerebellum—malignant glioma	0.000893	0.00988	CbGeAlD
Paclitaxel—MAP4—cerebellum—malignant glioma	0.000893	0.00988	CbGeAlD
Paclitaxel—Breast pain—Temozolomide—malignant glioma	0.000892	0.00541	CcSEcCtD
Paclitaxel—TUBB2A—telencephalon—malignant glioma	0.00089	0.00984	CbGeAlD
Paclitaxel—MAP2—spinal cord—malignant glioma	0.000887	0.00981	CbGeAlD
Paclitaxel—Thinking abnormal—Carmustine—malignant glioma	0.000879	0.00533	CcSEcCtD
Paclitaxel—Drug interaction—Carmustine—malignant glioma	0.000868	0.00526	CcSEcCtD
Paclitaxel—Viral infection—Temozolomide—malignant glioma	0.000861	0.00522	CcSEcCtD
Paclitaxel—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000856	0.00519	CcSEcCtD
Paclitaxel—Herpes simplex—Temozolomide—malignant glioma	0.000844	0.00512	CcSEcCtD
Paclitaxel—BCL2—central nervous system—malignant glioma	0.000831	0.00918	CbGeAlD
Paclitaxel—TUBB4B—retina—malignant glioma	0.00083	0.00917	CbGeAlD
Paclitaxel—Gait disturbance—Carmustine—malignant glioma	0.000825	0.005	CcSEcCtD
Paclitaxel—Hearing impaired—Temozolomide—malignant glioma	0.000817	0.00496	CcSEcCtD
Paclitaxel—Neck pain—Carmustine—malignant glioma	0.000815	0.00494	CcSEcCtD
Paclitaxel—Pulmonary embolism—Carmustine—malignant glioma	0.000805	0.00488	CcSEcCtD
Paclitaxel—Injection site reaction—Carmustine—malignant glioma	0.0008	0.00485	CcSEcCtD
Paclitaxel—Gait disturbance—Temozolomide—malignant glioma	0.000797	0.00483	CcSEcCtD
Paclitaxel—Respiratory failure—Temozolomide—malignant glioma	0.000792	0.0048	CcSEcCtD
Paclitaxel—Musculoskeletal pain—Temozolomide—malignant glioma	0.000787	0.00477	CcSEcCtD
Paclitaxel—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000778	0.00472	CcSEcCtD
Paclitaxel—Pulmonary embolism—Temozolomide—malignant glioma	0.000778	0.00472	CcSEcCtD
Paclitaxel—Urinary incontinence—Carmustine—malignant glioma	0.000777	0.00471	CcSEcCtD
Paclitaxel—TUBB4A—medulla oblongata—malignant glioma	0.000769	0.0085	CbGeAlD
Paclitaxel—ABCC10—telencephalon—malignant glioma	0.000769	0.0085	CbGeAlD
Paclitaxel—Skin exfoliation—Carmustine—malignant glioma	0.000769	0.00466	CcSEcCtD
Paclitaxel—Candida infection—Carmustine—malignant glioma	0.000769	0.00466	CcSEcCtD
Paclitaxel—TUBB4B—telencephalon—malignant glioma	0.000763	0.00844	CbGeAlD
Paclitaxel—Neuropathy—Carmustine—malignant glioma	0.000756	0.00458	CcSEcCtD
Paclitaxel—Influenza like illness—Temozolomide—malignant glioma	0.000756	0.00458	CcSEcCtD
Paclitaxel—Urinary incontinence—Temozolomide—malignant glioma	0.000751	0.00456	CcSEcCtD
Paclitaxel—TUBB2B—medulla oblongata—malignant glioma	0.000743	0.00822	CbGeAlD
Paclitaxel—Skin exfoliation—Temozolomide—malignant glioma	0.000743	0.0045	CcSEcCtD
Paclitaxel—Candida infection—Temozolomide—malignant glioma	0.000743	0.0045	CcSEcCtD
Paclitaxel—Neuropathy—Temozolomide—malignant glioma	0.00073	0.00443	CcSEcCtD
Paclitaxel—Neoplasm—Carmustine—malignant glioma	0.000728	0.00441	CcSEcCtD
Paclitaxel—TUBB3—brain—malignant glioma	0.000726	0.00802	CbGeAlD
Paclitaxel—MAP4—brain—malignant glioma	0.000726	0.00802	CbGeAlD
Paclitaxel—MAP2—central nervous system—malignant glioma	0.00072	0.00796	CbGeAlD
Paclitaxel—Dry eye—Temozolomide—malignant glioma	0.000719	0.00436	CcSEcCtD
Paclitaxel—TUBB1—brain—malignant glioma	0.00071	0.00784	CbGeAlD
Paclitaxel—MAP2—cerebellum—malignant glioma	0.000704	0.00778	CbGeAlD
Paclitaxel—Neoplasm—Temozolomide—malignant glioma	0.000703	0.00427	CcSEcCtD
Paclitaxel—TUBB—medulla oblongata—malignant glioma	0.000703	0.00777	CbGeAlD
Paclitaxel—TUBB4A—midbrain—malignant glioma	0.000703	0.00777	CbGeAlD
Paclitaxel—Abnormal vision—Carmustine—malignant glioma	0.000702	0.00426	CcSEcCtD
Paclitaxel—TUBB2A—medulla oblongata—malignant glioma	0.0007	0.00773	CbGeAlD
Paclitaxel—Mental disability—Carmustine—malignant glioma	0.000699	0.00424	CcSEcCtD
Paclitaxel—Sepsis—Carmustine—malignant glioma	0.000699	0.00424	CcSEcCtD
Paclitaxel—TUBB6—medulla oblongata—malignant glioma	0.00069	0.00763	CbGeAlD
Paclitaxel—TUBB4A—spinal cord—malignant glioma	0.000686	0.00758	CbGeAlD
Paclitaxel—TUBB2B—midbrain—malignant glioma	0.000679	0.00751	CbGeAlD
Paclitaxel—Abnormal vision—Temozolomide—malignant glioma	0.000679	0.00411	CcSEcCtD
Paclitaxel—Phlebitis—Carmustine—malignant glioma	0.000678	0.00411	CcSEcCtD
Paclitaxel—Mental disability—Temozolomide—malignant glioma	0.000675	0.00409	CcSEcCtD
Paclitaxel—Thrombophlebitis—Carmustine—malignant glioma	0.000675	0.00409	CcSEcCtD
Paclitaxel—TUBB2B—spinal cord—malignant glioma	0.000663	0.00733	CbGeAlD
Paclitaxel—Swelling—Carmustine—malignant glioma	0.000662	0.00402	CcSEcCtD
Paclitaxel—Ear pain—Temozolomide—malignant glioma	0.000662	0.00401	CcSEcCtD
Paclitaxel—BCL2—brain—malignant glioma	0.00066	0.00729	CbGeAlD
Paclitaxel—Thrombophlebitis—Temozolomide—malignant glioma	0.000652	0.00396	CcSEcCtD
Paclitaxel—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000649	0.00394	CcSEcCtD
Paclitaxel—Eye pain—Carmustine—malignant glioma	0.000647	0.00393	CcSEcCtD
Paclitaxel—TUBB—midbrain—malignant glioma	0.000643	0.00711	CbGeAlD
Paclitaxel—TUBB2A—midbrain—malignant glioma	0.000639	0.00707	CbGeAlD
Paclitaxel—Injury—Carmustine—malignant glioma	0.000636	0.00386	CcSEcCtD
Paclitaxel—Deafness—Temozolomide—malignant glioma	0.000631	0.00383	CcSEcCtD
Paclitaxel—TUBB6—midbrain—malignant glioma	0.000631	0.00697	CbGeAlD
Paclitaxel—TUBB—spinal cord—malignant glioma	0.000627	0.00693	CbGeAlD
Paclitaxel—Eye pain—Temozolomide—malignant glioma	0.000626	0.00379	CcSEcCtD
Paclitaxel—TUBB2A—spinal cord—malignant glioma	0.000624	0.0069	CbGeAlD
Paclitaxel—Nasal congestion—Temozolomide—malignant glioma	0.00062	0.00376	CcSEcCtD
Paclitaxel—TUBB6—spinal cord—malignant glioma	0.000615	0.0068	CbGeAlD
Paclitaxel—CYP1B1—telencephalon—malignant glioma	0.000605	0.00668	CbGeAlD
Paclitaxel—ABCC10—medulla oblongata—malignant glioma	0.000604	0.00668	CbGeAlD
Paclitaxel—Hot flush—Temozolomide—malignant glioma	0.000604	0.00366	CcSEcCtD
Paclitaxel—TUBB4B—medulla oblongata—malignant glioma	0.0006	0.00663	CbGeAlD
Paclitaxel—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000599	0.00363	CcSEcCtD
Paclitaxel—Menopausal symptoms—Temozolomide—malignant glioma	0.000599	0.00363	CcSEcCtD
Paclitaxel—Hyponatraemia—Carmustine—malignant glioma	0.000587	0.00356	CcSEcCtD
Paclitaxel—MAP2—brain—malignant glioma	0.000571	0.00632	CbGeAlD
Paclitaxel—TUBB4A—central nervous system—malignant glioma	0.000556	0.00615	CbGeAlD
Paclitaxel—ABCC10—midbrain—malignant glioma	0.000552	0.0061	CbGeAlD
Paclitaxel—Ataxia—Carmustine—malignant glioma	0.000549	0.00333	CcSEcCtD
Paclitaxel—TUBB4B—midbrain—malignant glioma	0.000548	0.00606	CbGeAlD
Paclitaxel—ABCC1—telencephalon—malignant glioma	0.000544	0.00601	CbGeAlD
Paclitaxel—TUBB4A—cerebellum—malignant glioma	0.000544	0.00601	CbGeAlD
Paclitaxel—Liver function test abnormal—Carmustine—malignant glioma	0.00054	0.00327	CcSEcCtD
Paclitaxel—ABCC10—spinal cord—malignant glioma	0.000539	0.00595	CbGeAlD
Paclitaxel—TUBB2B—central nervous system—malignant glioma	0.000538	0.00594	CbGeAlD
Paclitaxel—Mood swings—Temozolomide—malignant glioma	0.000535	0.00324	CcSEcCtD
Paclitaxel—TUBB4B—spinal cord—malignant glioma	0.000535	0.00591	CbGeAlD
Paclitaxel—Hypokalaemia—Carmustine—malignant glioma	0.000532	0.00322	CcSEcCtD
Paclitaxel—Ataxia—Temozolomide—malignant glioma	0.000531	0.00322	CcSEcCtD
Paclitaxel—TUBB2B—cerebellum—malignant glioma	0.000525	0.00581	CbGeAlD
Paclitaxel—Dehydration—Temozolomide—malignant glioma	0.000525	0.00318	CcSEcCtD
Paclitaxel—Dry skin—Temozolomide—malignant glioma	0.000518	0.00314	CcSEcCtD
Paclitaxel—Muscular weakness—Carmustine—malignant glioma	0.000515	0.00313	CcSEcCtD
Paclitaxel—Hypokalaemia—Temozolomide—malignant glioma	0.000514	0.00312	CcSEcCtD
Paclitaxel—Breast disorder—Temozolomide—malignant glioma	0.00051	0.00309	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000509	0.00308	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000509	0.00308	CcSEcCtD
Paclitaxel—TUBB2A—central nervous system—malignant glioma	0.000506	0.00559	CbGeAlD
Paclitaxel—Dysphagia—Carmustine—malignant glioma	0.000505	0.00306	CcSEcCtD
Paclitaxel—TUBB6—central nervous system—malignant glioma	0.000499	0.00552	CbGeAlD
Paclitaxel—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000498	0.00302	CcSEcCtD
Paclitaxel—Muscular weakness—Temozolomide—malignant glioma	0.000498	0.00302	CcSEcCtD
Paclitaxel—TUBB—cerebellum—malignant glioma	0.000497	0.0055	CbGeAlD
Paclitaxel—TUBB2A—cerebellum—malignant glioma	0.000495	0.00547	CbGeAlD
Paclitaxel—Abdominal distension—Temozolomide—malignant glioma	0.000491	0.00298	CcSEcCtD
Paclitaxel—Dysphagia—Temozolomide—malignant glioma	0.000488	0.00296	CcSEcCtD
Paclitaxel—TUBB6—cerebellum—malignant glioma	0.000488	0.00539	CbGeAlD
Paclitaxel—Pancytopenia—Carmustine—malignant glioma	0.00048	0.00291	CcSEcCtD
Paclitaxel—Sweating increased—Temozolomide—malignant glioma	0.000475	0.00288	CcSEcCtD
Paclitaxel—Neutropenia—Carmustine—malignant glioma	0.000472	0.00286	CcSEcCtD
Paclitaxel—Bronchitis—Temozolomide—malignant glioma	0.000469	0.00285	CcSEcCtD
Paclitaxel—Pancytopenia—Temozolomide—malignant glioma	0.000464	0.00281	CcSEcCtD
Paclitaxel—ABCB1—blood vessel—malignant glioma	0.000458	0.00506	CbGeAlD
Paclitaxel—Neutropenia—Temozolomide—malignant glioma	0.000456	0.00277	CcSEcCtD
Paclitaxel—Dysuria—Temozolomide—malignant glioma	0.000456	0.00277	CcSEcCtD
Paclitaxel—Hyperglycaemia—Carmustine—malignant glioma	0.000456	0.00276	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000454	0.00275	CcSEcCtD
Paclitaxel—Pneumonia—Carmustine—malignant glioma	0.000453	0.00275	CcSEcCtD
Paclitaxel—Pollakiuria—Temozolomide—malignant glioma	0.000451	0.00273	CcSEcCtD
Paclitaxel—ABCG2—telencephalon—malignant glioma	0.00045	0.00498	CbGeAlD
Paclitaxel—Depression—Carmustine—malignant glioma	0.000449	0.00272	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Temozolomide—malignant glioma	0.000446	0.0027	CcSEcCtD
Paclitaxel—Weight increased—Temozolomide—malignant glioma	0.000444	0.00269	CcSEcCtD
Paclitaxel—Renal failure—Carmustine—malignant glioma	0.000443	0.00268	CcSEcCtD
Paclitaxel—TUBB4A—brain—malignant glioma	0.000442	0.00488	CbGeAlD
Paclitaxel—Weight decreased—Temozolomide—malignant glioma	0.000442	0.00268	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Carmustine—malignant glioma	0.000441	0.00268	CcSEcCtD
Paclitaxel—Hyperglycaemia—Temozolomide—malignant glioma	0.00044	0.00267	CcSEcCtD
Paclitaxel—Stomatitis—Carmustine—malignant glioma	0.000439	0.00266	CcSEcCtD
Paclitaxel—Urinary tract infection—Carmustine—malignant glioma	0.000438	0.00265	CcSEcCtD
Paclitaxel—Pneumonia—Temozolomide—malignant glioma	0.000438	0.00265	CcSEcCtD
Paclitaxel—Infestation—Temozolomide—malignant glioma	0.000435	0.00264	CcSEcCtD
Paclitaxel—Infestation NOS—Temozolomide—malignant glioma	0.000435	0.00264	CcSEcCtD
Paclitaxel—Depression—Temozolomide—malignant glioma	0.000434	0.00263	CcSEcCtD
Paclitaxel—TUBB4B—central nervous system—malignant glioma	0.000434	0.0048	CbGeAlD
Paclitaxel—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000431	0.00262	CcSEcCtD
Paclitaxel—ABCC10—cerebellum—malignant glioma	0.000427	0.00472	CbGeAlD
Paclitaxel—TUBB2B—brain—malignant glioma	0.000427	0.00472	CbGeAlD
Paclitaxel—Neuropathy peripheral—Temozolomide—malignant glioma	0.000427	0.00259	CcSEcCtD
Paclitaxel—Stomatitis—Temozolomide—malignant glioma	0.000424	0.00257	CcSEcCtD
Paclitaxel—TUBB4B—cerebellum—malignant glioma	0.000424	0.00469	CbGeAlD
Paclitaxel—Urinary tract infection—Temozolomide—malignant glioma	0.000423	0.00257	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Temozolomide—malignant glioma	0.000412	0.0025	CcSEcCtD
Paclitaxel—Sinusitis—Temozolomide—malignant glioma	0.000408	0.00248	CcSEcCtD
Paclitaxel—Haemoglobin—Carmustine—malignant glioma	0.000406	0.00246	CcSEcCtD
Paclitaxel—Haemorrhage—Carmustine—malignant glioma	0.000404	0.00245	CcSEcCtD
Paclitaxel—TUBB—brain—malignant glioma	0.000404	0.00446	CbGeAlD
Paclitaxel—Hypoaesthesia—Carmustine—malignant glioma	0.000402	0.00244	CcSEcCtD
Paclitaxel—TUBB2A—brain—malignant glioma	0.000402	0.00444	CbGeAlD
Paclitaxel—Oedema peripheral—Carmustine—malignant glioma	0.000398	0.00241	CcSEcCtD
Paclitaxel—Connective tissue disorder—Carmustine—malignant glioma	0.000397	0.00241	CcSEcCtD
Paclitaxel—TUBB6—brain—malignant glioma	0.000396	0.00438	CbGeAlD
Paclitaxel—Haemoglobin—Temozolomide—malignant glioma	0.000393	0.00238	CcSEcCtD
Paclitaxel—Haemorrhage—Temozolomide—malignant glioma	0.000391	0.00237	CcSEcCtD
Paclitaxel—Visual impairment—Carmustine—malignant glioma	0.00039	0.00236	CcSEcCtD
Paclitaxel—Hypoaesthesia—Temozolomide—malignant glioma	0.000389	0.00236	CcSEcCtD
Paclitaxel—Pharyngitis—Temozolomide—malignant glioma	0.000388	0.00235	CcSEcCtD
Paclitaxel—Urinary tract disorder—Temozolomide—malignant glioma	0.000386	0.00234	CcSEcCtD
Paclitaxel—Oedema peripheral—Temozolomide—malignant glioma	0.000385	0.00233	CcSEcCtD
Paclitaxel—Connective tissue disorder—Temozolomide—malignant glioma	0.000384	0.00233	CcSEcCtD
Paclitaxel—Urethral disorder—Temozolomide—malignant glioma	0.000383	0.00232	CcSEcCtD
Paclitaxel—Eye disorder—Carmustine—malignant glioma	0.000378	0.00229	CcSEcCtD
Paclitaxel—Visual impairment—Temozolomide—malignant glioma	0.000377	0.00228	CcSEcCtD
Paclitaxel—Flushing—Carmustine—malignant glioma	0.000375	0.00228	CcSEcCtD
Paclitaxel—Erythema multiforme—Temozolomide—malignant glioma	0.000369	0.00224	CcSEcCtD
Paclitaxel—CYP19A1—central nervous system—malignant glioma	0.000368	0.00406	CbGeAlD
Paclitaxel—Eye disorder—Temozolomide—malignant glioma	0.000365	0.00221	CcSEcCtD
Paclitaxel—Tinnitus—Temozolomide—malignant glioma	0.000364	0.00221	CcSEcCtD
Paclitaxel—Flushing—Temozolomide—malignant glioma	0.000363	0.0022	CcSEcCtD
Paclitaxel—Cardiac disorder—Temozolomide—malignant glioma	0.000363	0.0022	CcSEcCtD
Paclitaxel—Arrhythmia—Carmustine—malignant glioma	0.000361	0.00219	CcSEcCtD
Paclitaxel—Alopecia—Carmustine—malignant glioma	0.000357	0.00217	CcSEcCtD
Paclitaxel—Angiopathy—Temozolomide—malignant glioma	0.000354	0.00215	CcSEcCtD
Paclitaxel—Mental disorder—Carmustine—malignant glioma	0.000354	0.00215	CcSEcCtD
Paclitaxel—ABCG2—medulla oblongata—malignant glioma	0.000354	0.00391	CbGeAlD
Paclitaxel—Immune system disorder—Temozolomide—malignant glioma	0.000353	0.00214	CcSEcCtD
Paclitaxel—Mediastinal disorder—Temozolomide—malignant glioma	0.000352	0.00214	CcSEcCtD
Paclitaxel—Malnutrition—Carmustine—malignant glioma	0.000352	0.00213	CcSEcCtD
Paclitaxel—Erythema—Carmustine—malignant glioma	0.000352	0.00213	CcSEcCtD
Paclitaxel—Chills—Temozolomide—malignant glioma	0.000351	0.00213	CcSEcCtD
Paclitaxel—ABCC10—brain—malignant glioma	0.000347	0.00384	CbGeAlD
Paclitaxel—Alopecia—Temozolomide—malignant glioma	0.000345	0.00209	CcSEcCtD
Paclitaxel—TUBB4B—brain—malignant glioma	0.000344	0.00381	CbGeAlD
Paclitaxel—CYP1B1—central nervous system—malignant glioma	0.000344	0.0038	CbGeAlD
Paclitaxel—Mental disorder—Temozolomide—malignant glioma	0.000342	0.00208	CcSEcCtD
Paclitaxel—Back pain—Carmustine—malignant glioma	0.00034	0.00206	CcSEcCtD
Paclitaxel—Malnutrition—Temozolomide—malignant glioma	0.00034	0.00206	CcSEcCtD
Paclitaxel—Erythema—Temozolomide—malignant glioma	0.00034	0.00206	CcSEcCtD
Paclitaxel—CYP1B1—cerebellum—malignant glioma	0.000336	0.00371	CbGeAlD
Paclitaxel—Dysgeusia—Temozolomide—malignant glioma	0.000333	0.00202	CcSEcCtD
Paclitaxel—Vision blurred—Carmustine—malignant glioma	0.000332	0.00201	CcSEcCtD
Paclitaxel—Tremor—Carmustine—malignant glioma	0.00033	0.002	CcSEcCtD
Paclitaxel—Back pain—Temozolomide—malignant glioma	0.000329	0.00199	CcSEcCtD
Paclitaxel—Anaemia—Carmustine—malignant glioma	0.000325	0.00197	CcSEcCtD
Paclitaxel—Agitation—Carmustine—malignant glioma	0.000323	0.00196	CcSEcCtD
Paclitaxel—ABCG2—midbrain—malignant glioma	0.000323	0.00357	CbGeAlD
Paclitaxel—Vision blurred—Temozolomide—malignant glioma	0.000321	0.00194	CcSEcCtD
Paclitaxel—Tremor—Temozolomide—malignant glioma	0.000319	0.00193	CcSEcCtD
Paclitaxel—Ill-defined disorder—Temozolomide—malignant glioma	0.000316	0.00191	CcSEcCtD
Paclitaxel—ABCG2—spinal cord—malignant glioma	0.000315	0.00349	CbGeAlD
Paclitaxel—Leukopenia—Carmustine—malignant glioma	0.000315	0.00191	CcSEcCtD
Paclitaxel—Anaemia—Temozolomide—malignant glioma	0.000314	0.00191	CcSEcCtD
Paclitaxel—Agitation—Temozolomide—malignant glioma	0.000313	0.0019	CcSEcCtD
Paclitaxel—Angioedema—Temozolomide—malignant glioma	0.000311	0.00188	CcSEcCtD
Paclitaxel—Malaise—Temozolomide—malignant glioma	0.000307	0.00186	CcSEcCtD
Paclitaxel—Vertigo—Temozolomide—malignant glioma	0.000306	0.00185	CcSEcCtD
Paclitaxel—Convulsion—Carmustine—malignant glioma	0.000305	0.00185	CcSEcCtD
Paclitaxel—Leukopenia—Temozolomide—malignant glioma	0.000304	0.00185	CcSEcCtD
Paclitaxel—Hypertension—Carmustine—malignant glioma	0.000304	0.00184	CcSEcCtD
Paclitaxel—ABCC1—cerebellum—malignant glioma	0.000302	0.00334	CbGeAlD
Paclitaxel—Palpitations—Temozolomide—malignant glioma	0.000301	0.00182	CcSEcCtD
Paclitaxel—Chest pain—Carmustine—malignant glioma	0.0003	0.00182	CcSEcCtD
Paclitaxel—Myalgia—Carmustine—malignant glioma	0.0003	0.00182	CcSEcCtD
Paclitaxel—Anxiety—Carmustine—malignant glioma	0.000299	0.00181	CcSEcCtD
Paclitaxel—Cough—Temozolomide—malignant glioma	0.000297	0.0018	CcSEcCtD
Paclitaxel—Convulsion—Temozolomide—malignant glioma	0.000295	0.00179	CcSEcCtD
Paclitaxel—Hypertension—Temozolomide—malignant glioma	0.000294	0.00178	CcSEcCtD
Paclitaxel—CYP19A1—brain—malignant glioma	0.000292	0.00323	CbGeAlD
Paclitaxel—Confusional state—Carmustine—malignant glioma	0.00029	0.00176	CcSEcCtD
Paclitaxel—Arthralgia—Temozolomide—malignant glioma	0.00029	0.00176	CcSEcCtD
Paclitaxel—Myalgia—Temozolomide—malignant glioma	0.00029	0.00176	CcSEcCtD
Paclitaxel—Anxiety—Temozolomide—malignant glioma	0.000289	0.00175	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000288	0.00174	CcSEcCtD
Paclitaxel—Oedema—Carmustine—malignant glioma	0.000287	0.00174	CcSEcCtD
Paclitaxel—Discomfort—Temozolomide—malignant glioma	0.000286	0.00173	CcSEcCtD
Paclitaxel—Infection—Carmustine—malignant glioma	0.000285	0.00173	CcSEcCtD
Paclitaxel—Dry mouth—Temozolomide—malignant glioma	0.000283	0.00172	CcSEcCtD
Paclitaxel—Thrombocytopenia—Carmustine—malignant glioma	0.000281	0.00171	CcSEcCtD
Paclitaxel—Tachycardia—Carmustine—malignant glioma	0.00028	0.0017	CcSEcCtD
Paclitaxel—Confusional state—Temozolomide—malignant glioma	0.00028	0.0017	CcSEcCtD
Paclitaxel—Anaphylactic shock—Temozolomide—malignant glioma	0.000278	0.00168	CcSEcCtD
Paclitaxel—Oedema—Temozolomide—malignant glioma	0.000278	0.00168	CcSEcCtD
Paclitaxel—Infection—Temozolomide—malignant glioma	0.000276	0.00167	CcSEcCtD
Paclitaxel—Anorexia—Carmustine—malignant glioma	0.000274	0.00166	CcSEcCtD
Paclitaxel—ABCB1—embryo—malignant glioma	0.000273	0.00302	CbGeAlD
Paclitaxel—CYP1B1—brain—malignant glioma	0.000273	0.00302	CbGeAlD
Paclitaxel—Nervous system disorder—Temozolomide—malignant glioma	0.000272	0.00165	CcSEcCtD
Paclitaxel—Thrombocytopenia—Temozolomide—malignant glioma	0.000272	0.00165	CcSEcCtD
Paclitaxel—Skin disorder—Temozolomide—malignant glioma	0.00027	0.00163	CcSEcCtD
Paclitaxel—Hypotension—Carmustine—malignant glioma	0.000268	0.00163	CcSEcCtD
Paclitaxel—Hyperhidrosis—Temozolomide—malignant glioma	0.000268	0.00163	CcSEcCtD
Paclitaxel—Anorexia—Temozolomide—malignant glioma	0.000265	0.0016	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000262	0.00159	CcSEcCtD
Paclitaxel—Insomnia—Carmustine—malignant glioma	0.00026	0.00158	CcSEcCtD
Paclitaxel—Paraesthesia—Carmustine—malignant glioma	0.000258	0.00156	CcSEcCtD
Paclitaxel—Dyspnoea—Carmustine—malignant glioma	0.000256	0.00155	CcSEcCtD
Paclitaxel—Somnolence—Carmustine—malignant glioma	0.000255	0.00155	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000253	0.00153	CcSEcCtD
Paclitaxel—Insomnia—Temozolomide—malignant glioma	0.000251	0.00152	CcSEcCtD
Paclitaxel—ABCG2—cerebellum—malignant glioma	0.00025	0.00276	CbGeAlD
Paclitaxel—Decreased appetite—Carmustine—malignant glioma	0.00025	0.00151	CcSEcCtD
Paclitaxel—Paraesthesia—Temozolomide—malignant glioma	0.000249	0.00151	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Carmustine—malignant glioma	0.000248	0.0015	CcSEcCtD
Paclitaxel—Dyspnoea—Temozolomide—malignant glioma	0.000247	0.0015	CcSEcCtD
Paclitaxel—Somnolence—Temozolomide—malignant glioma	0.000247	0.0015	CcSEcCtD
Paclitaxel—Pain—Carmustine—malignant glioma	0.000246	0.00149	CcSEcCtD
Paclitaxel—Constipation—Carmustine—malignant glioma	0.000246	0.00149	CcSEcCtD
Paclitaxel—ABCC1—brain—malignant glioma	0.000245	0.00271	CbGeAlD
Paclitaxel—Dyspepsia—Temozolomide—malignant glioma	0.000244	0.00148	CcSEcCtD
Paclitaxel—ABCB1—retina—malignant glioma	0.000241	0.00267	CbGeAlD
Paclitaxel—Decreased appetite—Temozolomide—malignant glioma	0.000241	0.00146	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00024	0.00145	CcSEcCtD
Paclitaxel—Fatigue—Temozolomide—malignant glioma	0.000239	0.00145	CcSEcCtD
Paclitaxel—Pain—Temozolomide—malignant glioma	0.000237	0.00144	CcSEcCtD
Paclitaxel—Constipation—Temozolomide—malignant glioma	0.000237	0.00144	CcSEcCtD
Paclitaxel—Feeling abnormal—Carmustine—malignant glioma	0.000237	0.00144	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Carmustine—malignant glioma	0.000235	0.00142	CcSEcCtD
Paclitaxel—Feeling abnormal—Temozolomide—malignant glioma	0.000229	0.00139	CcSEcCtD
Paclitaxel—Abdominal pain—Carmustine—malignant glioma	0.000227	0.00138	CcSEcCtD
Paclitaxel—Body temperature increased—Carmustine—malignant glioma	0.000227	0.00138	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Temozolomide—malignant glioma	0.000227	0.00138	CcSEcCtD
Paclitaxel—ABCB1—telencephalon—malignant glioma	0.000222	0.00245	CbGeAlD
Paclitaxel—Urticaria—Temozolomide—malignant glioma	0.000221	0.00134	CcSEcCtD
Paclitaxel—Abdominal pain—Temozolomide—malignant glioma	0.000219	0.00133	CcSEcCtD
Paclitaxel—Body temperature increased—Temozolomide—malignant glioma	0.000219	0.00133	CcSEcCtD
Paclitaxel—Hypersensitivity—Carmustine—malignant glioma	0.000212	0.00128	CcSEcCtD
Paclitaxel—CYP2C8—brain—malignant glioma	0.000209	0.00231	CbGeAlD
Paclitaxel—Asthenia—Carmustine—malignant glioma	0.000206	0.00125	CcSEcCtD
Paclitaxel—Hypersensitivity—Temozolomide—malignant glioma	0.000204	0.00124	CcSEcCtD
Paclitaxel—ABCG2—brain—malignant glioma	0.000203	0.00225	CbGeAlD
Paclitaxel—Asthenia—Temozolomide—malignant glioma	0.000199	0.00121	CcSEcCtD
Paclitaxel—Diarrhoea—Carmustine—malignant glioma	0.000197	0.00119	CcSEcCtD
Paclitaxel—Pruritus—Temozolomide—malignant glioma	0.000196	0.00119	CcSEcCtD
Paclitaxel—Dizziness—Carmustine—malignant glioma	0.00019	0.00115	CcSEcCtD
Paclitaxel—Diarrhoea—Temozolomide—malignant glioma	0.00019	0.00115	CcSEcCtD
Paclitaxel—Dizziness—Temozolomide—malignant glioma	0.000184	0.00111	CcSEcCtD
Paclitaxel—Vomiting—Carmustine—malignant glioma	0.000183	0.00111	CcSEcCtD
Paclitaxel—Rash—Carmustine—malignant glioma	0.000181	0.0011	CcSEcCtD
Paclitaxel—Dermatitis—Carmustine—malignant glioma	0.000181	0.0011	CcSEcCtD
Paclitaxel—Headache—Carmustine—malignant glioma	0.00018	0.00109	CcSEcCtD
Paclitaxel—CYP3A4—central nervous system—malignant glioma	0.000178	0.00197	CbGeAlD
Paclitaxel—Vomiting—Temozolomide—malignant glioma	0.000176	0.00107	CcSEcCtD
Paclitaxel—Rash—Temozolomide—malignant glioma	0.000175	0.00106	CcSEcCtD
Paclitaxel—Dermatitis—Temozolomide—malignant glioma	0.000175	0.00106	CcSEcCtD
Paclitaxel—ABCB1—medulla oblongata—malignant glioma	0.000174	0.00193	CbGeAlD
Paclitaxel—Headache—Temozolomide—malignant glioma	0.000174	0.00105	CcSEcCtD
Paclitaxel—Nausea—Carmustine—malignant glioma	0.000171	0.00103	CcSEcCtD
Paclitaxel—Nausea—Temozolomide—malignant glioma	0.000165	0.001	CcSEcCtD
Paclitaxel—ABCB1—midbrain—malignant glioma	0.000159	0.00176	CbGeAlD
Paclitaxel—ABCB1—spinal cord—malignant glioma	0.000156	0.00172	CbGeAlD
Paclitaxel—ABCB1—central nervous system—malignant glioma	0.000126	0.00139	CbGeAlD
Paclitaxel—ABCB1—cerebellum—malignant glioma	0.000123	0.00136	CbGeAlD
Paclitaxel—ABCB1—brain—malignant glioma	0.0001	0.00111	CbGeAlD
Paclitaxel—ABCB1—Metabolism—IDH2—malignant glioma	9.45e-06	5.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—IDH1—malignant glioma	9.33e-06	5.3e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.25e-06	5.25e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.21e-06	5.23e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.19e-06	5.22e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.13e-06	5.19e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSTP1—malignant glioma	9.12e-06	5.18e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSTP1—malignant glioma	9.08e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CAV1—malignant glioma	9.05e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—COX8A—malignant glioma	9.03e-06	5.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SPHK1—malignant glioma	9.03e-06	5.12e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL1B—malignant glioma	9.02e-06	5.12e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL2—malignant glioma	8.99e-06	5.1e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.91e-06	5.06e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP2B6—malignant glioma	8.88e-06	5.04e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CAT—malignant glioma	8.87e-06	5.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP2C18—malignant glioma	8.84e-06	5.02e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CAT—malignant glioma	8.83e-06	5.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—IDH2—malignant glioma	8.83e-06	5.01e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSTP1—malignant glioma	8.78e-06	4.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TERT—malignant glioma	8.78e-06	4.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HLA-A—malignant glioma	8.78e-06	4.98e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CG—malignant glioma	8.76e-06	4.97e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	8.72e-06	4.95e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.65e-06	4.91e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PDGFB—malignant glioma	8.57e-06	4.86e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CAT—malignant glioma	8.54e-06	4.85e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	8.53e-06	4.84e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGFR1—malignant glioma	8.52e-06	4.84e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PTEN—malignant glioma	8.46e-06	4.8e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PPARG—malignant glioma	8.46e-06	4.8e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HIF1A—malignant glioma	8.39e-06	4.77e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NCOR1—malignant glioma	8.38e-06	4.76e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—malignant glioma	8.37e-06	4.75e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NCOR1—malignant glioma	8.34e-06	4.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.34e-06	4.73e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.32e-06	4.73e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2B6—malignant glioma	8.3e-06	4.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTT1—malignant glioma	8.26e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CG—malignant glioma	8.24e-06	4.68e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—IDH1—malignant glioma	8.13e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	8.12e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CAV1—malignant glioma	8.12e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NCOR1—malignant glioma	8.07e-06	4.58e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	8.06e-06	4.57e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTP1—malignant glioma	7.99e-06	4.53e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—malignant glioma	7.96e-06	4.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTP1—malignant glioma	7.92e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SPHK1—malignant glioma	7.86e-06	4.46e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CAT—malignant glioma	7.77e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS1—malignant glioma	7.74e-06	4.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CAT—malignant glioma	7.7e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP2C18—malignant glioma	7.7e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—malignant glioma	7.7e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CD—malignant glioma	7.7e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ASMT—malignant glioma	7.68e-06	4.36e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BAD—malignant glioma	7.64e-06	4.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.59e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—IDH1—malignant glioma	7.59e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOTCH1—malignant glioma	7.56e-06	4.29e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—malignant glioma	7.56e-06	4.29e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD80—malignant glioma	7.41e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	7.4e-06	4.2e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APC—malignant glioma	7.4e-06	4.2e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SPHK1—malignant glioma	7.35e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NCOR1—malignant glioma	7.34e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.33e-06	4.16e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGF—malignant glioma	7.31e-06	4.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NCOR1—malignant glioma	7.28e-06	4.13e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTPN11—malignant glioma	7.27e-06	4.13e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CD—malignant glioma	7.25e-06	4.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BCAN—malignant glioma	7.22e-06	4.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.2e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—BCHE—malignant glioma	7.19e-06	4.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	7.16e-06	4.07e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTT1—malignant glioma	7.15e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC5A5—malignant glioma	7.1e-06	4.03e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—malignant glioma	6.95e-06	3.95e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—malignant glioma	6.87e-06	3.9e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CAV1—malignant glioma	6.83e-06	3.88e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CAV1—malignant glioma	6.8e-06	3.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.79e-06	3.85e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT2—malignant glioma	6.77e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CB—malignant glioma	6.71e-06	3.81e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS1—malignant glioma	6.7e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.68e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—malignant glioma	6.65e-06	3.78e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CAV1—malignant glioma	6.58e-06	3.73e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.52e-06	3.7e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CD—malignant glioma	6.5e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.5e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—malignant glioma	6.49e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CB—malignant glioma	6.32e-06	3.59e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.28e-06	3.57e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—malignant glioma	6.26e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTT1—malignant glioma	6.23e-06	3.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—BCHE—malignant glioma	6.23e-06	3.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGF2—malignant glioma	6.23e-06	3.53e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—malignant glioma	6.22e-06	3.53e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—malignant glioma	6.19e-06	3.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.18e-06	3.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC5A5—malignant glioma	6.15e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.05e-06	3.43e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—malignant glioma	6e-06	3.41e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—malignant glioma	5.99e-06	3.4e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CAV1—malignant glioma	5.98e-06	3.4e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—malignant glioma	5.98e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.97e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—malignant glioma	5.97e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CAV1—malignant glioma	5.93e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS1—malignant glioma	5.84e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MDM2—malignant glioma	5.82e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH2—malignant glioma	5.82e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTT1—malignant glioma	5.82e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.82e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RAF1—malignant glioma	5.8e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—malignant glioma	5.8e-06	3.29e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—malignant glioma	5.78e-06	3.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.77e-06	3.27e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—malignant glioma	5.74e-06	3.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—malignant glioma	5.72e-06	3.25e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CB—malignant glioma	5.67e-06	3.22e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—malignant glioma	5.62e-06	3.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAT—malignant glioma	5.57e-06	3.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.47e-06	3.11e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—malignant glioma	5.47e-06	3.1e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—malignant glioma	5.46e-06	3.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS1—malignant glioma	5.45e-06	3.1e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—malignant glioma	5.45e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—malignant glioma	5.44e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.43e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—BCHE—malignant glioma	5.43e-06	3.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—malignant glioma	5.4e-06	3.07e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—malignant glioma	5.36e-06	3.04e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—malignant glioma	5.27e-06	2.99e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—malignant glioma	5.26e-06	2.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NCOR1—malignant glioma	5.26e-06	2.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—malignant glioma	5.21e-06	2.96e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BCHE—malignant glioma	5.07e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.03e-06	2.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.01e-06	2.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH1—malignant glioma	5.01e-06	2.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—malignant glioma	4.96e-06	2.81e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.94e-06	2.8e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—malignant glioma	4.9e-06	2.78e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—malignant glioma	4.87e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SPHK1—malignant glioma	4.84e-06	2.75e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAT—malignant glioma	4.82e-06	2.74e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—malignant glioma	4.79e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—malignant glioma	4.77e-06	2.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—malignant glioma	4.75e-06	2.7e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—malignant glioma	4.75e-06	2.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.75e-06	2.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.74e-06	2.69e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—malignant glioma	4.72e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—malignant glioma	4.7e-06	2.67e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.69e-06	2.66e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—malignant glioma	4.59e-06	2.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NCOR1—malignant glioma	4.55e-06	2.59e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—malignant glioma	4.55e-06	2.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—malignant glioma	4.38e-06	2.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—malignant glioma	4.32e-06	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAV1—malignant glioma	4.29e-06	2.43e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAT—malignant glioma	4.2e-06	2.39e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—malignant glioma	4.18e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—malignant glioma	4.14e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—malignant glioma	4.14e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—malignant glioma	4.12e-06	2.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—malignant glioma	4.1e-06	2.33e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—malignant glioma	4.1e-06	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.09e-06	2.32e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—malignant glioma	4.09e-06	2.32e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—malignant glioma	4.07e-06	2.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—malignant glioma	4.03e-06	2.29e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—malignant glioma	3.98e-06	2.26e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NCOR1—malignant glioma	3.97e-06	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—malignant glioma	3.97e-06	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAT—malignant glioma	3.93e-06	2.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.9e-06	2.22e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—malignant glioma	3.85e-06	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTT1—malignant glioma	3.84e-06	2.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—malignant glioma	3.77e-06	2.14e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—malignant glioma	3.76e-06	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAV1—malignant glioma	3.71e-06	2.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOR1—malignant glioma	3.71e-06	2.1e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—malignant glioma	3.61e-06	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS1—malignant glioma	3.6e-06	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—malignant glioma	3.58e-06	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.55e-06	2.01e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—malignant glioma	3.45e-06	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.43e-06	1.95e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—malignant glioma	3.38e-06	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BCHE—malignant glioma	3.34e-06	1.9e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—malignant glioma	3.34e-06	1.9e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.3e-06	1.88e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—malignant glioma	3.26e-06	1.85e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAV1—malignant glioma	3.23e-06	1.84e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—malignant glioma	3.15e-06	1.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAV1—malignant glioma	3.02e-06	1.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.99e-06	1.7e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.97e-06	1.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—malignant glioma	2.96e-06	1.68e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—malignant glioma	2.95e-06	1.67e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—malignant glioma	2.91e-06	1.65e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—malignant glioma	2.89e-06	1.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.89e-06	1.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—malignant glioma	2.84e-06	1.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—malignant glioma	2.82e-06	1.6e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—malignant glioma	2.8e-06	1.59e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.75e-06	1.56e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—malignant glioma	2.66e-06	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—malignant glioma	2.66e-06	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.59e-06	1.47e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—malignant glioma	2.59e-06	1.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAT—malignant glioma	2.59e-06	1.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—malignant glioma	2.59e-06	1.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—malignant glioma	2.57e-06	1.46e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—malignant glioma	2.55e-06	1.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.52e-06	1.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOR1—malignant glioma	2.44e-06	1.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.42e-06	1.37e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—malignant glioma	2.37e-06	1.35e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—malignant glioma	2.36e-06	1.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—malignant glioma	2.29e-06	1.3e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—malignant glioma	2.26e-06	1.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—malignant glioma	2.24e-06	1.27e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—malignant glioma	2.24e-06	1.27e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.11e-06	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—malignant glioma	2.09e-06	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—malignant glioma	2.08e-06	1.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—malignant glioma	2.06e-06	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAV1—malignant glioma	1.99e-06	1.13e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—malignant glioma	1.95e-06	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.82e-06	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—malignant glioma	1.82e-06	1.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.82e-06	1.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—malignant glioma	1.75e-06	9.95e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.6e-06	9.06e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.58e-06	8.97e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—malignant glioma	1.49e-06	8.46e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.39e-06	7.9e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—malignant glioma	1.38e-06	7.83e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—malignant glioma	1.38e-06	7.81e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—malignant glioma	1.29e-06	7.33e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.29e-06	7.3e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—malignant glioma	1.2e-06	6.82e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—malignant glioma	1.12e-06	6.38e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—malignant glioma	1.05e-06	5.96e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.48e-07	4.81e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—malignant glioma	6.93e-07	3.93e-06	CbGpPWpGaD
